All Stories

  1. Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia

    Article • European Respiratory Journal, May 2016, European Respiratory Society (ERS)

    Dr JAVIER GARAU, antoni Torres, Dr CATIA CILLONIZ

  2. Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates

    Article • International Journal of Antimicrobial Agents, January 2016, Elsevier

    Dr JAVIER GARAU, Dr Ferran Navarro, Dr Elena Espejo

  3. Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed

    Article • Journal of Infection, October 2015, Elsevier

    Dr JAVIER GARAU, Dr Elena Espejo

  4. Diagnosis of Stroke-Associated Pneumonia

    Article • Stroke, June 2015, Wolters Kluwer Health

    Dr JAVIER GARAU, Prof Christine C Roffe

  5. Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections

    Article • Expert Review of Anti-infective Therapy, June 2015, Taylor & Francis

    Dr JAVIER GARAU

  6. The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation

    Article • Future Microbiology, June 2015, Future Medicine

    Dr JAVIER GARAU

  7. Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study

    Article • BMC Infectious Diseases, January 2015, Springer Science + Business Media

    Dr JAVIER GARAU

  8. Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance

    Article • Journal of Global Antimicrobial Resistance, December 2014, Elsevier

    Dr JAVIER GARAU

  9. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study

    Article • Journal of Medical Economics, July 2014, Informa Healthcare

    Dr JAVIER GARAU

  10. Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study

    Article • BMC Pulmonary Medicine, January 2014, Springer Science + Business Media

    Dr JAVIER GARAU

  11. Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study

    Article • BMJ Open Respiratory Research, January 2014, Springer Science + Business Media

    Dr JAVIER GARAU

  12. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

    Article • The Lancet Infectious Diseases, September 2013, Elsevier

    Dr JAVIER GARAU

  13. Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH

    Article • BMJ Open Respiratory Research, January 2013, Springer Science + Business Media

    Dr JAVIER GARAU

  14. Bacteriemias en la población de mayores de 80 años

    Article • Revista Clínica Española, June 2012, Elsevier

    Dr JAVIER GARAU

  15. Current Management Of Patients Hospitalized With Community-Acquired Pneumonia Across Europe (2010-2011): Assessment Of Clinical Practice Patterns And Real-Life Effectiveness Of Antibiotics (REACH Study)

    Article • May 2012, American Thoracic Society

    Dr JAVIER GARAU

  16. Health Economic Analyses Of Current Management Of Patients Hospitalized With Community-Acquired Pneumonia In Europe (2010-2011) (REtrospective Study To Assess The Clinical Management Of Patients With Moderate-To-Severe CSSTI Or CAP Infections In The Ho...

    Article • May 2012, American Thoracic Society

    Dr JAVIER GARAU

  17. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance

    Article • International Journal of Antimicrobial Agents, February 2012, Elsevier

    Dr JAVIER GARAU

  18. Factors affecting the development of systemic inflammatory response syndrome in pneumococcal infections

    Article • Current Opinion in Infectious Diseases, June 2011, Wolters Kluwer Health

    Dr JAVIER GARAU

  19. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?

    Article • International Journal of Antimicrobial Agents, March 2011, Elsevier

    Dr JAVIER GARAU

  20. New trends in infective endocarditis

    Article • Enfermedades Infecciosas y Microbiología Clínica, March 2011, Elsevier

    Dr JAVIER GARAU

  21. The Remaining Challenge of Pneumonia

    Article • The Pediatric Infectious Disease Journal, January 2011, Wolters Kluwer Health

    Dr JAVIER GARAU

  22. Marking November 12, 2010 – World Pneumonia Day: Where are we, where are vaccines?

    Article • Human Vaccines, November 2010, Taylor & Francis

    Dr JAVIER GARAU

  23. Nosocomial infections: new therapeutic alternatives

    Article • Expert Review of Anti-infective Therapy, November 2010, Taylor & Francis

    Dr JAVIER GARAU

  24. Prudent use of antimicrobial agents: Revisiting concepts and estimating perspectives in a global world

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2010, Elsevier

    Professor Fernando Baquero, Dr JAVIER GARAU

  25. Las relaciones con la microbiología: la visión desde otras especialidades

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2010, Elsevier

    Dr JAVIER GARAU

  26. Infección intraabdominal: hechos clave

    Article • Enfermedades Infecciosas y Microbiología Clínica, September 2010, Elsevier

    Dr JAVIER GARAU

  27. Clinical Efficacy of Moxifloxacin Versus Comparator Therapies for Community-Acquired Pneumonia Caused byLegionellaspp.

    Article • Journal of Chemotherapy, August 2010, Taylor & Francis

    Dr JAVIER GARAU

  28. Javier Garau: eyeing the horizons of infectious disease

    Article • The Lancet Infectious Diseases, April 2010, Elsevier

    Dr JAVIER GARAU

  29. Of mice and men: innate immunity in pneumococcal pneumonia

    Article • International Journal of Antimicrobial Agents, February 2010, Elsevier

    Dr JAVIER GARAU

  30. Mortality of Tuberculosis in Very Old People

    Article • Journal of the American Geriatrics Society, January 2010, Wiley

    Dr JAVIER GARAU

  31. ESCMID Consensus concerning MRSA

    Article • Clinical Microbiology and Infection, December 2009, Elsevier

    Dr JAVIER GARAU

  32. A preventable killer: Pneumonia

    Article • Clinical Microbiology and Infection, November 2009, Elsevier

    Dr JAVIER GARAU

  33. Mortality Associated with Cefepime Therapy among Neutropenic Patients

    Article • Clinical Infectious Diseases, September 2009, Oxford University Press (OUP)

    Dr JAVIER GARAU

  34. A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients

    Article • Clinical Infectious Diseases, September 2009, Oxford University Press (OUP)

    Dr JAVIER GARAU

  35. Mortalidad posthospitalaria en pacientes reingresadores por EPOC. Utilidad del índice BODE

    Article • Revista Clínica Española, September 2009, Elsevier

    Dr JAVIER GARAU

  36. The impact of time on the systemic inflammatory response in pneumococcal pneumonia

    Article • European Respiratory Journal, July 2009, European Respiratory Society (ERS)

    Dr JAVIER GARAU

  37. New insights concerning methicillin-resistant Staphylococcus aureus disease

    Article • Clinical Microbiology and Infection, February 2009, Elsevier

    Dr JAVIER GARAU

  38. Management of methicillin-resistant Staphylococcus aureus infections

    Article • Clinical Microbiology and Infection, February 2009, Elsevier

    Dr JAVIER GARAU

  39. Piomiositis no traumática recurrente en un jugador de fútbol profesional

    Article • Apunts Medicina de l Esport, January 2009, Elsevier

    Dr JAVIER GARAU

  40. La infectología en Europa y América

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2008, Elsevier

    Dr JAVIER GARAU

  41. Reply to Mohapatra et al.

    Article • Clinical Infectious Diseases, September 2008, Oxford University Press (OUP)

    Dr JAVIER GARAU

  42. Moxifloxacin Monotherapy Is Effective in Hospitalized Patients with Community‐Acquired Pneumonia: The MOTIV Study—A Randomized Clinical Trial

    Article • Clinical Infectious Diseases, May 2008, Oxford University Press (OUP)

    Dr JAVIER GARAU

  43. Update on bacterial pathogens: virulence and resistance

    Article • Enfermedades Infecciosas y Microbiología Clínica, April 2008, Elsevier

    Dr JAVIER GARAU

  44. Community-acquired pneumonia

    Article • The Lancet, February 2008, Elsevier

    Dr JAVIER GARAU

  45. Living with ESBLs

    Article • Clinical Microbiology and Infection, January 2008, Elsevier

    Dr JAVIER GARAU

  46. Other antimicrobials of interest in the era of extended-spectrum β-lactamases: fosfomycin, nitrofurantoin and tigecycline

    Article • Clinical Microbiology and Infection, January 2008, Elsevier

    Dr JAVIER GARAU

  47. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens

    Article • International Journal of Antimicrobial Agents, December 2007, Elsevier

    Dr JAVIER GARAU

  48. Effects of systemic steroids in patients with severe community-acquired pneumonia

    Article • European Respiratory Journal, November 2007, European Respiratory Society (ERS)

    Dr JAVIER GARAU

  49. Living with ESBLs

    Article • Clinical Microbiology and Infection, October 2007, Elsevier

    Dr JAVIER GARAU

  50. Capsular Types and Predicting Patient Outcomes in Pneumococcal Bacteremia

    Article • Clinical Infectious Diseases, July 2007, Oxford University Press (OUP)

    Dr JAVIER GARAU

  51. Update on bacterial infections in immunosuppressed patients

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2007, Elsevier

    Dr JAVIER GARAU

  52. Antibiotic resistance

    Article • October 2006, Taylor & Francis

    Dr JAVIER GARAU

  53. Impact of amoxicillin, associated or not with clavulanic acid, on pharyngeal colonization and selection of Streptococcus pneumoniae resistance in children under 5 years of age

    Article • European Journal of Pediatrics, October 2006, Springer Science + Business Media

    Dr JAVIER GARAU

  54. Management of cSSTIs:the role of daptomycin

    Article • Current Medical Research and Opinion, September 2006, Informa Healthcare

    Dr JAVIER GARAU

  55. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia

    Article • International Journal of Antimicrobial Agents, September 2006, Elsevier

    Dr JAVIER GARAU

  56. Impact of antibiotic restrictions: the ethical perspective

    Article • Clinical Microbiology and Infection, August 2006, Elsevier

    Dr JAVIER GARAU

  57. El tratamiento antibiótico de la legionelosis

    Article • Enfermedades Infecciosas y Microbiología Clínica, July 2006, Elsevier

    Dr JAVIER GARAU

  58. Similarity between Human and Chicken Escherichia coli Isolates in Relation to Ciprofloxacin Resistance Status

    Article • The Journal of Infectious Diseases, July 2006, Oxford University Press (OUP)

    Dr JAVIER GARAU

  59. Risk Factors for Hospital Readmission in Patients with Chronic Obstructive Pulmonary Disease

    Article • Respiration, January 2006, Karger Publishers

    Dr JAVIER GARAU

  60. Invasive Pneumococcal Disease in Children: Changing Serotypes and Clinical Expression of Disease

    Article • Clinical Infectious Diseases, December 2005, Oxford University Press (OUP)

    Dr JAVIER GARAU

  61. Systemic Steroid Treatment of Paradoxical Upgrading Reaction in Patients with Lymph Node Tuberculosis

    Article • Clinical Infectious Diseases, September 2005, Oxford University Press (OUP)

    Dr JAVIER GARAU

  62. Factores de riesgo y pronósticos de la neumonía nosocomial en los pacientes no ingresados en unidades de cuidados intensivos

    Article • Enfermedades Infecciosas y Microbiología Clínica, September 2005, Elsevier

    Dr JAVIER GARAU

  63. Both penicillin and amoxycillin should be tested in antimicrobial surveillance for Streptococcus pneumoniae

    Article • Clinical Microbiology and Infection, May 2005, Elsevier

    Dr JAVIER GARAU

  64. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains

    Article • International Journal of Antimicrobial Agents, February 2005, Elsevier

    Dr Michael R Jacobs, Dr JAVIER GARAU

  65. Role of beta-lactam agents in the treatment of community-acquired pneumonia

    Article • European Journal of Clinical Microbiology & Infectious Diseases, February 2005, Springer Science + Business Media

    Dr JAVIER GARAU

  66. Hospitalización a domicilio y neumonía adquirida en la comunidad. Réplica

    Article • Enfermedades Infecciosas y Microbiología Clínica, August 2004, Elsevier

    Dr JAVIER GARAU

  67. Guidelines for Empiric Antimicrobial Prescribing in Community-Acquired Pneumonia

    Article • CHEST Journal, May 2004, Elsevier

    Dr JAVIER GARAU

  68. Ingresos, estancia y mortalidad de las neumonías adquiridas en la comunidad en un hospital de agudos. Correlación entre el índice pronóstico de severidad y los criterios clínicos tradicionales de valoración de la gravedad

    Article • Enfermedades Infecciosas y Microbiología Clínica, February 2004, Elsevier

    Dr JAVIER GARAU

  69. Hospitalización a domicilio y neumonía adquirida en la comunidad. Réplica

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Dr JAVIER GARAU

  70. Ingresos, estancia y mortalidad de las neumonías adquiridas en la comunidad en un hospital de agudos. Correlación entre el índice pronóstico de severidad y los criterios clínicos tradicionales de valoración de la gravedad

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Dr JAVIER GARAU

  71. Performance in practice: bacteriological efficacy in patients with drug‐resistant S. pneumoniae

    Article • Clinical Microbiology and Infection, January 2004, Elsevier

    Dr JAVIER GARAU

  72. Accurate diagnosis and appropriate treatment of acute bacterial rhinosinusitis: minimizing bacterial resistance

    Article • Clinical Therapeutics, July 2003, Elsevier

    Dr JAVIER GARAU

  73. Clinical microbiological case: esophageal lesion in an aids patient

    Article • Clinical Microbiology and Infection, May 2003, Elsevier

    Dr JAVIER GARAU

  74. Clinical microbiological case: esophageal lesion in an aids patient

    Article • Clinical Microbiology and Infection, May 2003, Elsevier

    Dr JAVIER GARAU

  75. Reply

    Article • Clinical Infectious Diseases, April 2003, Oxford University Press (OUP)

    Dr JAVIER GARAU

  76. Pseudomonas aeruginosa pneumonia

    Article • Current Opinion in Infectious Diseases, April 2003, Wolters Kluwer Health

    Dr JAVIER GARAU

  77. Why do we need to eradicate pathogens in respiratory tract infections?

    Article • International Journal of Infectious Diseases, March 2003, Elsevier

    Dr JAVIER GARAU

  78. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistantEscherichia coli

    Article • Cancer, January 2003, Wiley

    Dr JAVIER GARAU

  79. Resistencia de Streptococcus pneumoniae a los betalactámicos y manejo de la meningitis neumocócica

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2003, Elsevier

    Dr JAVIER GARAU

  80. Resistencia de Streptococcus pneumoniae a los betalactámicos y manejo de la meningitis neumocócica

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2003, Elsevier

    Dr JAVIER GARAU

  81. Pulmonary Capillary Hemangiomatosis Associated with Primary Pulmonary Hypertension

    Article • Medicine, November 2002, Wolters Kluwer Health

    Dr JAVIER GARAU

  82. Hospital‐Acquired Pneumococcal Bacteremia

    Article • Clinical Infectious Diseases, September 2002, Oxford University Press (OUP)

    Dr JAVIER GARAU

  83. Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

    Article • Clinical Infectious Diseases, September 2002, Oxford University Press (OUP)

    Dr JAVIER GARAU

  84. The efficacy and safety of oral pharmacokinetically enhanced amoxycillin–clavulanate 2000/125 mg, twice daily, versus oral amoxycillin–clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults

    Article • International Journal of Antimicrobial Agents, August 2002, Elsevier

    Dr JAVIER GARAU

  85. Treatment of drug-resistant pneumococcal pneumonia

    Article • The Lancet Infectious Diseases, July 2002, Elsevier

    Dr JAVIER GARAU

  86. Mortality After Hospitalization for COPD

    Article • CHEST Journal, May 2002, Elsevier

    Dr JAVIER GARAU

  87. Evolución de la sensibilidad de 235 cepas de Helicobacter pylori entre 1995 y 1998 e impacto del tratamiento antibiótico

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2002, Elsevier

    Dr JAVIER GARAU

  88. Per Migliorare la Guarigione di Pazienti Affetti da Infezione del Tratto Respiratorio

    Article • Journal of Chemotherapy, January 2002, Taylor & Francis

    Dr JAVIER GARAU

  89. Lymphocutaneous syndrome due to Scedosporium apiospermum

    Article • Clinical Microbiology and Infection, November 2001, Elsevier

    Dr JAVIER GARAU

  90. Lung Biopsy in Pulmonary Veno-Occlusive Disease

    Article • CHEST Journal, October 2001, Elsevier

    Dr JAVIER GARAU

  91. The clinical impact of macrolide resistance in pneumococcal respiratory infections

    Article • International Journal of Antimicrobial Agents, September 2001, Elsevier

    Dr JAVIER GARAU

  92. Have guidelines had an impact on antimicrobial resistance?☆

    Article • Seminars in Respiratory Infections, September 2001, Elsevier

    Dr JAVIER GARAU

  93. Clinical failures: the tip of the iceberg?

    Article • Respiratory Medicine, June 2001, Elsevier

    Dr JAVIER GARAU

  94. Empiema pleural por Gemella morbillorum

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2001, Elsevier

    Dr JAVIER GARAU

  95. Introduction: Strategies for Prevention and Treatment of Sepsis in Post-Surgical Intensive Care

    Article • Journal of Chemotherapy, January 2001, Taylor & Francis

    Dr JAVIER GARAU

  96. Transesophageal echocardiography and antibiotic prophylaxis for infective endocarditis

    Article • Clinical Microbiology and Infection, March 2000, Elsevier

    Dr JAVIER GARAU

  97. Mycoplasma hominis catheter-related infection in a patient with multiple trauma

    Article • Clinical Microbiology and Infection, February 2000, Elsevier

    Dr JAVIER GARAU

  98. Spontaneous spleen rupture during typhoid fever

    Article • International Journal of Infectious Diseases, January 2000, Elsevier

    Dr JAVIER GARAU

  99. Tratamiento del aspergiloma con anfotericina B intracavitaria

    Article • Revista Clínica Española, January 2000, Elsevier

    Dr JAVIER GARAU

  100. New concepts of sepsis and their practical value

    Article • Clinical Microbiology and Infection, March 1999, Elsevier

    Dr JAVIER GARAU

  101. Basing Empiric Treatment Choices for Respiratory Tract Infection on the Results of the Alexander Project

    Article • Journal of Chemotherapy, January 1999, Taylor & Francis

    Dr JAVIER GARAU

  102. CHANGING PATTERNS OF ETIOLOGY AND RESISTANCE IN COMMUNITY-ACQUIRED RESPIRATORY TRACT INFECTIONS

    Article • Infectious Diseases in Clinical Practice, August 1998, Wolters Kluwer Health

    Dr JAVIER GARAU

  103. Thoracic infection caused by Streptococcus milleri

    Article • European Respiratory Journal, August 1998, European Respiratory Society (ERS)

    Dr JAVIER GARAU

  104. The Clinical Potential of Fourth-Generation Cephalosporins

    Article • Diagnostic Microbiology and Infectious Disease, July 1998, Elsevier

    Dr JAVIER GARAU

  105. Clinical Strategies for Serious Infection: A European Perspective

    Article • Diagnostic Microbiology and Infectious Disease, June 1998, Elsevier

    Dr JAVIER GARAU

  106. Upper respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones

    Article • Clinical Microbiology and Infection, April 1998, Elsevier

    Dr JAVIER GARAU

  107. The Growing Problem of Nosocomial Bacterial Resistance

    Article • Clinical Drug Investigation, January 1998, Springer Science + Business Media

    Dr JAVIER GARAU

  108. Group B Streptococcal Meningitis in Adults: Report of Twelve Cases and Review

    Article • Clinical Infectious Diseases, November 1997, Oxford University Press (OUP)

    Dr JAVIER GARAU

  109. 30 years of penicillin-resistant S pneumoniae: myth or reality?

    Article • The Lancet, July 1997, Elsevier

    Dr JAVIER GARAU

  110. Empirical antibacterial treatment for sepsis and the role of glycopeptides: recommendations from a European panel

    Article • Clinical Microbiology and Infection, June 1997, Elsevier

    Dr JAVIER GARAU

  111. Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility

    Article • Clinical Microbiology and Infection, April 1997, Elsevier

    Dr JAVIER GARAU

  112. A case of Q fever endocarditis treated medically: 9 years of follow-up

    Article • Infection, March 1997, Springer Science + Business Media

    Dr JAVIER GARAU

  113. Current trends in the antibiotic therapy of uncomplicated Acute Otitis Media in children: concluding remarks

    Article • Clinical Microbiology and Infection, January 1997, Elsevier

    Dr JAVIER GARAU

  114. Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen

    Article • Journal of Hospital Infection, November 1996, Elsevier

    Dr Ferran Navarro, Dr JAVIER GARAU

  115. Clinical perspectives on the management of community-acquired pneumonia

    Article • Diagnostic Microbiology and Infectious Disease, August 1996, Elsevier

    Dr JAVIER GARAU

  116. Treatment of Cerebral Aspergillosis with Itraconazole: Do High Doses Improve the Prognosis?

    Article • Clinical Infectious Diseases, December 1995, Oxford University Press (OUP)

    Dr JAVIER GARAU

  117. Meningococcal meningitis with ‘normal’ cerebrospinal fluid

    Article • Journal of Infection, November 1994, Elsevier

    Dr JAVIER GARAU

  118. Beta-lactamases: Current situation and clinical importance

    Article • Intensive Care Medicine, July 1994, Springer Science + Business Media

    Dr JAVIER GARAU

  119. Nocardia asteroides Peritonitis in a Patient with Cirrhosis and Human Immunodeficiency Virus Infection

    Article • Clinical Infectious Diseases, June 1994, Oxford University Press (OUP)

    Dr JAVIER GARAU

  120. Postoperative complications due to methicillin-resistant staphylococcus aureus (MRSA) in an elderly patient: management and control of MRSA

    Article • Journal of Hospital Infection, November 1992, Elsevier

    Dr JAVIER GARAU

  121. Penicillin-resistant pneumococci and community-acquired pneumonia

    Article • The Lancet, April 1992, Elsevier

    Dr JAVIER GARAU

  122. Treatment of bacterial infections with intravenous or intramuscular imipenem/cilastatin

    Article • Current Opinion in Infectious Diseases, March 1991, Wolters Kluwer Health

    Dr JAVIER GARAU

  123. Intramuscular Imipenem/Cilastatin in Multiple-Dose Treatment Regimens: Review of the Worldwide Clinical Experience

    Article • Chemotherapy, January 1991, Karger Publishers

    Dr JAVIER GARAU

  124. Neisseria meningitidis with reduced sensitivity to penicillin: Observations in 10 Children

    Article • Scandinavian Journal of Infectious Diseases, January 1991, Taylor & Francis

    Dr JAVIER GARAU

  125. Nonspecific Pleural Effusion vs Malignant and Granulomatous Pleural Disease

    Article • CHEST Journal, February 1990, Elsevier

    Dr JAVIER GARAU

  126. CONTROLLED TRIAL OF ENDOSCOPIC SCLEROSIS IN BLEEDING PEPTIC ULCERS

    Article • The Lancet, December 1987, Elsevier

    Dr JAVIER GARAU

  127. Exophiala dermatitidis de Hoog from a valvular aortal prothesis

    Article • Mycopathologia, July 1987, Springer Science + Business Media

    Dr JAVIER GARAU

  128. Trimethoprim-sulfamethoxazole treatment of cholangitis complicating congenital hepatic fibrosis

    Article • The Pediatric Infectious Disease Journal, May 1986, Wolters Kluwer Health

    Dr JAVIER GARAU

  129. Catheter sepsis: The clue is the hub

    Article • American Journal of Infection Control, December 1985, Elsevier

    Dr JAVIER GARAU

  130. Bilateral and Symmetrical Osteomyelitis due to Gram-Negative Bacilli:A Report on Two Cases

    Article • Scandinavian Journal of Rheumatology, January 1985, Taylor & Francis

    Dr JAVIER GARAU

  131. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen β -lactam antibiotics

    Article • Journal of Antimicrobial Chemotherapy, January 1984, Oxford University Press (OUP)

    Dr JAVIER GARAU

  132. Cotrimoxazole resistance in pneumococci

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 1983, Springer Science + Business Media

    Dr JAVIER GARAU

  133. Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community-acquired pneumococcal disease.

    Article • Antimicrobial Agents and Chemotherapy, April 1983, ASM Journals

    Dr JAVIER GARAU

  134. BACTERIA IN TOTAL PARENTERAL NUTRITION CATHETERS: WHERE DO THEY COME FROM?

    Article • The Lancet, March 1983, Elsevier

    Dr JAVIER GARAU

  135. P.60 An outbreak of coagulase negative staphylococci catheter sepsis due to hub infection

    Article • Clinical Nutrition, January 1983, Elsevier

    Dr JAVIER GARAU

  136. CHLORAMPHENICOL-RESISTANT PNEUMOCOCCI

    Article • The Lancet, July 1981, Elsevier

    Dr JAVIER GARAU

  137. Spontaneous Cytomegalovirus Mononucleosis With Conjunctivitis

    Article • Archives of Internal Medicine, November 1977, American Medical Association (AMA)

    Dr JAVIER GARAU

  138. Spontaneous cytomegalovirus mononucleosis with conjunctivitis

    Article • Archives of Internal Medicine, November 1977, American Medical Association (AMA)

    Dr JAVIER GARAU

  139. Alternaria Osteomyelitis

    Article • Annals of Internal Medicine, June 1977, American College of Physicians

    Dr JAVIER GARAU

  140. Macrolides and Ketolides

    Article • Wiley

    Dr JAVIER GARAU